Actinium Pharmaceuticals, Inc.ATNMNYSE
Loading
Debt to Assets Over TimeNormalizing
Percentile Rank50
3Y CAGR+74.4%
5Y CAGR-30.1%
Year-over-Year Change
Debt-to-assets ratio
3Y CAGR
+74.4%/yr
Annual compound
5Y CAGR
-30.1%/yr
Recent acceleration
Percentile
P50
Within normal range
vs 5Y Ago
0.2x
Contraction
Streak
1 yr
Consecutive declineNormalizing
| Period | Value | YoY Change |
|---|---|---|
| 2024 | 0.02 | -21.2% |
| 2023 | 0.03 | +14.8% |
| 2022 | 0.02 | +486.1% |
| 2021 | 0.00 | -65.3% |
| 2020 | 0.01 | -90.9% |
| 2019 | 0.12 | +593.9% |
| 2018 | 0.02 | - |
| 2017 | 0.00 | - |
| 2016 | 0.00 | -100.0% |
| 2015 | 0.01 | - |